You have no items in your shopping cart.
Availability: In Stock
Brand Name : VaxiFlu -4 Vaccine
Composition : Inactivated influenza vaccine (NA)
Manufactured By : Zydus Cadila
Form : vial
Packing : 0.5 ml in 1 vial
VaxiFlu -4 Vaccine Description:
VaxiFlu -4 Vaccine is an inactivated vaccine (made from a dead virus). It helps develop immunity by forming antibodies, which are proteins that protect against infection caused by viruses present in the vaccine.
VaxiFlu -4 Vaccine is used for Prevention of influenza. It is also used to prevent H1N1 influenza (Swine flu). It is recommended in people at greater risk of experiencing complications of influenza (flu), including adults over the age of 65, pregnant women, children under the age of 5, and patients with weakened immune systems due to chronic illness.
Headache, Weakness, Injection site allergic reaction.
Your doctor or nurse will give you this medicine. Kindly do not self administer.
Buy VaxiFlu -4 Vaccine Online From India At Best Price
If you are looking to buy Inactivated influenza vaccine (NA) (0.5 ml in 1 vial) online at affordable prices, then Drugssquare.com is your one-stop solution. Drugssquare is a leading supplier, exporter and retailer of generic & branded prescription drugs in the U.S. and all around the world. From Cancer to Hepatitis, and from AIDS to Kidney Disease, the company delivers medicines for all kinds of complex diseases, with savings of up to 70% or more.
Order Online to Get VaxiFlu -4 Vaccine in -
South East Asia - China, Cambodia, Indonesia, Malaysia, Philippines, Singapore, Thailand, Vietnam, Hong Kong, Japan, South Korea.
United Arab Emirates (UAE) - Iran, Saudi Arabia, Jordan.
North America - Venezuela, USA (United States of America), Suriname.
South America - Argentina, Chile, Colombia, Peru, Venezuela.
Europe - Romania, Georgia, Turkey, UK (United Kingdom), Ukraine, Latvia.
Russia CIS - Moldova, Uzbekistan, Kyrgyzstan.
African Countries - Nigeria, Kenya, Morocco, Libya, Zimbabwe.
Other Countries - Malaysia, Egypt, Australia, Italy and New Zealand.